The development of Asyn PET has been challenging due to the limited quantities of Asyn fibrils present in the PD brain tissue and the occurrence of other pathologic amyloid aggregates such as amyloid-beta and tau fibrils in a subset of PD autopsy cases. Here, MAPT is linked to Parkinson disease.